Clinical Utility of Subcutaneous Furosemide in Patients Presenting With Early Signs of Fluid Overload

NCT03359161 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

9

Enrollment

OTHER

Sponsor class

Stopped Development of first generation device discontinued.

Conditions

Heart Failure

Interventions

COMBINATION_PRODUCT: sc2Wear Furosemide Infusor

Sponsor

Steward St. Elizabeth's Medical Center of Boston, Inc.